April 22, 2025

Marketdata LLC has just released a new market study: “The U.S. Meal Replacements Market: Retail & MLM Channels”, April 2025. This 77-page report analyses the meal replacements and retail appetite suppressants market in the U.S.

The $5.1 billion U.S. meal replacements market has held up fairly well the past few years, despite strong competition for dieter dollars from the GLP-1 drugs, but they were affected. Growth is forecast for 2025 and 2028. As a DIY weight loss strategy, meal replacement shakes and nutrition bars are still popular, are easily accessible, inexpensive, and they don’t have side effects.

Companies selling meal replacements lost $1.5 billion in sales to the GLP-1 drugs market in 2023-2024 – most of the loss from Medifast. Some competitors have added the GLP-1 drugs to their programs to position themselves for a new future. High protein meal replacements have been positioned as an adjunct to the weight loss drugs.

Some Findings:

• The U.S. meal replacements market was estimated to be worth $5.1 billion in 2024, growing to $5.29 billion this year.
• meal replacements sales were $3.0 billion and retail appetite suppressants sales totaled $2.08 billion.
• Most of the $1.55 billion in sales lost during 2023-2024 was attributed to Medifast’s lower revenues.
• Meal replacements are still a popular weight loss DIY option, as they are easily obtained, have no side effects, and are relatively inexpensive.
• Meal replacements are being positioned as an adjunct to GLP-1 drugs, to retain muscle due to their high protein nature.
• Multi-level marketing firms are very active in this market: Medifast had 2024 sales of $602 million and Herbalife posted $567  million. The Atkins line, by Simply Good Foods, generated $492 million. MLM channels account for 32% of all meal replacements sales.

About The Report

This 77-page Marketdata report is a completely updated analysis of the U.S. meal replacements and OTC appetite suppressants market -– how they have been affected by and are responding to the popular GLP-1 drugs. This is the most comprehensive investigation of the U.S. meal replacements market published by anyone worldwide. Report contains 21 tables & charts.

Included… dollar value & growth rate of the market (early 1980s to 2024 and 2025 & 2028 forecasts), latest market trends and company developments, status reports for retail and MLM meal replacements and weight loss supplements, major distribution channels, and growth drivers. Analysis of retail versus MLM sales channels. Analysis of the medical weight loss programs market and competition from GLP-1 drugs.

10 Competitor profiles for: Medifast, Herbalife, Slim-Fast (Glanbia), Simply Good Foods (Atkins Nutritionals), BeachBody, Visalis Life Sciences, Isagenix, Shaklee, AMWAY (Quixtar), and Nu-Skin.

Purchase This Report:

The report may be purchased at the Marketdata website: marketdataenterprises.com, here: Or, call 813-971-8080.

marketdataenterprises.com/reports/#!/The-U-S-Meal-Replacements-Market-April-2025-77-pp-Mkt-Research-Report/p/744455616

Price: $995.